# Safety and Efficacy Study of rhPTH(1-84) in Subjects With Hypoparathyroidism

> **NCT03364738** · PHASE3 · TERMINATED · sponsor: **Shire** · enrollment: 22 (actual)

## Conditions studied

- Hypoparathyroidism

## Interventions

- **BIOLOGICAL:** rhPTH(1-84)

## Key facts

- **NCT ID:** NCT03364738
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-09-26
- **Primary completion:** 2020-04-14
- **Final completion:** 2020-04-14
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** The study was terminated due to Takeda commercial Natpara recall.
- **Last updated:** 2022-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03364738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03364738, "Safety and Efficacy Study of rhPTH(1-84) in Subjects With Hypoparathyroidism". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03364738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*